These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma. Comtois R, Beauregard H, Hardy J, Robert F, Somma M. Clin Endocrinol (Oxf); 1993 Jun 20; 38(6):601-7. PubMed ID: 8392915 [Abstract] [Full Text] [Related]
46. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours. Benker G, Gieshoff B, Freundlieb O, Windeck R, Schulte HM, Lancranjan I, Reinwein D. Clin Endocrinol (Oxf); 1986 May 20; 24(5):505-13. PubMed ID: 3791649 [Abstract] [Full Text] [Related]
53. Immunocytochemical growth hormone and prolactin in pituitary adenomas causing acromegaly and their relationship to basal serum hormone levels and the growth response to thyrotrophin releasing hormone. Nieuwenhuijzen Kruseman AC, Bots GT, Roelfsema F, Frölich M, Van Dulken H. Clin Endocrinol (Oxf); 1983 Jul 20; 19(1):1-8. PubMed ID: 6413097 [No Abstract] [Full Text] [Related]
55. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay. Parsons JA, Peterson EK, Hartfel MA. Endocrinology; 1984 May 20; 114(5):1812-7. PubMed ID: 6714167 [Abstract] [Full Text] [Related]
56. Prolactin receptors in human pituitary adenomas. Ciccarelli E, Faccani G, Longo A, Dalle Ore G, Papotti M, Grottoli S, Razzore P, Ghè C, Muccioli G. Clin Endocrinol (Oxf); 1995 May 20; 42(5):487-91. PubMed ID: 7621567 [Abstract] [Full Text] [Related]
57. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine. Lloyd HM, Jacobi JM, Willgoss DA. Clin Endocrinol (Oxf); 1995 Jul 20; 43(1):79-85. PubMed ID: 7641414 [Abstract] [Full Text] [Related]